Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Mar 31:2024:2042069.
doi: 10.1155/2024/2042069. eCollection 2024.

Myofascial Release for the Treatment of Tension-Type, Cervicogenic Headache or Migraine: A Systematic Review and Meta-Analysis

Affiliations
Meta-Analysis

Myofascial Release for the Treatment of Tension-Type, Cervicogenic Headache or Migraine: A Systematic Review and Meta-Analysis

Zhoupeng Lu et al. Pain Res Manag. .

Abstract

Objective: To assess the effectiveness of myofascial release (MFR) techniques on the intensity of headache pain and associated disability in patients with tension-type headache (TTH), cervicogenic headache (CGH), or migraine.

Design: A systematic review and meta-analysis.

Methods: Eight databases were searched on September 15, 2023, including PubMed, Scopus, Web of Science, CINAHL, Cochrane Library, Embase, CNKI, and Wanfang Database. The risk of bias was evaluated utilizing the Cochrane Risk of Bias 2 (RoB 2) tool.

Results: Pooled results showed that MFR intervention significantly reduces pain intensity [SMD = -2.01, 95% CI (-2.98, -1.03), I2 = 90%, P < 0.001] and improves disability [SMD = -1.3, 95% CI (-1.82, -0.79), I2 = 74%, P < 0.001]. Subgroup analysis based on the type of headache revealed significant reductions in pain intensity for CGH [SMD = -2.01, 95% CI (-2.73, -1.29), I2 = 63%, P < 0.001], TTH [SMD = -0.86, 95% CI (-1.52, -0.20), I2 = 50%, P=0.01] and migraine [SMD = -6.52, 95% CI (-8.15, -4.89), P < 0.001] and in disability for CGH [SMD = -1.45, 95% CI (-2.07, -0.83), I2 = 0%, P < 0.001]; TTH [SMD = -0.98, 95% CI (-1.32, -0.65), I2 = 0%, P < 0.001] but not migraine [SMD = -2.44, 95% CI (-6.04, 1.16), I2 = 97%, P=0.18].

Conclusion: The meta-analysis results indicate that MFR intervention can significantly alleviate pain and disability in TTH and CGH. For migraine, however, the results were inconsistent, and there was only moderate quality evidence of disability improvement for TTH and CGH. In contrast, the quality of other evidence was low or very low.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
The process of literature retrieval.
Figure 2
Figure 2
Risk of bias summary for randomized controlled trials.
Figure 3
Figure 3
Forest plot of pain intensity.
Figure 4
Figure 4
Forest plot of disability.
Figure 5
Figure 5
Funnel plot.

References

    1. Stovner L., Hagen K., Jensen R., et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia . 2007;27(3):193–210. doi: 10.1111/j.1468-2982.2007.01288.x. - DOI - PubMed
    1. Jensen R., Stovner L. J. Epidemiology and comorbidity of headache. The Lancet Neurology . 2008;7(4):354–361. doi: 10.1016/S1474-4422(08)70062-0. - DOI - PubMed
    1. Headache classification committee of the international headache society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia . 2018;38(1):1–211. doi: 10.1177/0333102417738202. - DOI - PubMed
    1. Sjaastad O., Saunte C., Hovdahl H., Breivik H., Grønbâk E. Cervicogenic headache. An hypothesis. Cephalalgia . 1983;3(4):249–256. doi: 10.1046/j.1468-2982.1983.0304249.x. - DOI - PubMed
    1. Sjaastad O., Bakketeig L. S. Prevalence of cervicogenic headache: Vågå study of headache epidemiology. Acta Neurologica Scandinavica . 2008;117(3):173–180. doi: 10.1111/j.1600-0404.2007.00962.x. - DOI - PubMed

Publication types